MicroRNA (miR)-1297 blocks AMD expression, sensitizes glioma cells to temozolomide treatment, and exerts similar actions in glioma cells treated with temozolomide as those reported in AMD knockdown glioma cells [16]. Here, AMD1 is linked to central nervous system cancer.